يعرض 1 - 10 نتائج من 259 نتيجة بحث عن '"DOGU, Mehmet Hilmi"', وقت الاستعلام: 0.87s تنقيح النتائج
  1. 1
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: Mediterranean Journal of Hematology and Infectious Diseases; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Doğu, M. H., Tekgündüz, A. İ. E., Deveci, B., Korkmaz, G., Cömert, M., Sevindik, Ö. G. . Serin, İ. (2023). Gilteritinib (XOSPATA (R)) in Turkey: Early access program results. Mediterranean Journal of Hematology and Infectious Diseases, 15(1). https://doi.org/10.4084/MJHID.2023.031Test; https://doi.org/10.4084/MJHID.2023.031Test; https://hdl.handle.net/20.500.12511/10979Test; 15; Q3; 000983087400001; 2-s2.0-85160615870; Q2

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المساهمون: İstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Mehmet Hilmi Doğu / 0000-0001-7237-2637, Rafet Eren / 0000-0003-0973-6279, Doğu, Mehmet Hilmi, Eren, Rafet, Mehmet Hilmi Doğu / W-2255-2017, Rafet Eren / GCU-9466-2022, Mehmet Hilmi Doğu / 55212747300, Rafet Eren / 57148626000

    مصطلحات موضوعية: Hodgkin lymphoma, EORTC QLQ-C30, QLQ-HL27, Quality Of Life

    وصف الملف: application/pdf

    العلاقة: Acta Oncologica Turcica; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; GEMİCİ A, SERİN İ, EROL V, DOĞU M, İNCE İ, EREN R, TEKİNALP A, KARAKUŞ V, SEVİNDİK Ö (2022). Quality of Life Assessment with EORTC QLQ in Patients with Hodgkin Lymphoma: Multicenter Study. ACTA ONCOLOGICA TURCICA, 55(2), 128 - 138. 10.5505/aot.2022.25991; http://dx.doi.org/10.5505/aot.2022.25991Test; https://hdl.handle.net/20.500.12713/3790Test; 55; 128; 138

  5. 5
    دورية أكاديمية

    المساهمون: İstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Mehmet Hilmi Doğu / 0000-0001-7237-2637, Cem Dane / 0000-0002-7498-2153, Doğu, Mehmet Hilmi, Dane, Cem, Mehmet Hilmi Doğu / W-2255-2017, Cem Dane / A-1285-2011, Mehmet Hilmi Doğu / 55212747300, Cem Dane / 57678682300

    مصطلحات موضوعية: COVID-19, LDH/lymphocyte Ratio (LLR), Pregnancy, Prognosis

    وصف الملف: application/pdf

    العلاقة: Journal of Perinatal Medicine; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Dogu, S. Y., Serin, I., Dogu, M. H., Guleroglu, F. Y., & Dane, C. (2022). Efficacy of the lactate dehydrogenase (LDH)/lymphocyte ratio (LLR) to reduce the need for X-ray in pregnant patients with COVID-19. Journal of Perinatal Medicine, doi:10.1515/jpm-2021-0341; https://doi.org/10.1515/jpm-2021-0341Test; https://hdl.handle.net/20.500.12713/2794Test

  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
  9. 9
    دورية أكاديمية

    المساهمون: Tıp Fakültesi, orcid:0000-0002-9216-2802, orcid:0000-0002-5603-1178, orcid:0000-0003-4919-0282, orcid:0000-0002-1172-8668, orcid:0000-0003-1716-539X, orcid:0000-0002-4265-8105, orcid:0000-0003-3489-296X, orcid:0000-0002-1218-8165, orcid:0000-0002-1559-8047, orcid:0000-0002-6961-8971, orcid:0000-0002-4513-3486, orcid:0000-0001-9105-6429, orcid:0000-0002-4764-2348, orcid:0000-0001-7471-5453, orcid:0000-0002-5717-3936, orcid:0000-0001-7237-2637, orcid:0000-0001-5590-972X, orcid:0000-0001-7342-1760, orcid:0000-0001-9967-2357

    وصف الملف: application/pdf

    العلاقة: https://doi.org/10.4274/tjh.galenos.2022.2022.0052Test; Turkish Journal of Haematology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://hdl.handle.net/20.500.12445/2308Test; 39; 170; 177

  10. 10
    دورية أكاديمية